Senderowicz Adrian — SEC insider filings
SEC reporting owner CIK 1616230. 11 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2021-06-15 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 176,851 shares, $1,000,268 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 40,993 shares @ $11.17 ($457,757) in PUMA BIOTECHNOLOGY, INC., filed 2021-06-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | 10 | — | 6 legs · 176,851 sh · $1,000,268 | 6 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | Director | 1 | — | — | — |
Insider filings — Senderowicz Adrian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 3 | ANAVEX LIFE SCIENCES CORP. (AVXL) | Holdings only — no transactions reported | EDGAR |
| 2026-06-15 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 · Sale (S): 27,000 @ $7.20 | EDGAR |
| 2025-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 27,000 @ $3.40 | EDGAR |
| 2025-06-13 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2024-06-21 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2024-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 27,000 @ $3.33 | EDGAR |
| 2023-06-15 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 27,000 @ $3.45 · Grant/award (A): 27,000 @ $0 | EDGAR |
| 2022-06-21 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 27,858 @ $2.63 | EDGAR |
| 2022-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2021-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,858 @ $0 | EDGAR |
| 2021-06-15 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 40,993 @ $11.17 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1616230 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs